1246 related articles for article (PubMed ID: 22449317)
1. Bariatric surgery versus conventional medical therapy for type 2 diabetes.
Mingrone G; Panunzi S; De Gaetano A; Guidone C; Iaconelli A; Leccesi L; Nanni G; Pomp A; Castagneto M; Ghirlanda G; Rubino F
N Engl J Med; 2012 Apr; 366(17):1577-85. PubMed ID: 22449317
[TBL] [Abstract][Full Text] [Related]
2. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.
Mingrone G; Panunzi S; De Gaetano A; Guidone C; Iaconelli A; Nanni G; Castagneto M; Bornstein S; Rubino F
Lancet; 2015 Sep; 386(9997):964-73. PubMed ID: 26369473
[TBL] [Abstract][Full Text] [Related]
3. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.
Schauer PR; Bhatt DL; Kirwan JP; Wolski K; Aminian A; Brethauer SA; Navaneethan SD; Singh RP; Pothier CE; Nissen SE; Kashyap SR;
N Engl J Med; 2017 Feb; 376(7):641-651. PubMed ID: 28199805
[TBL] [Abstract][Full Text] [Related]
4. Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.
Schauer PR; Bhatt DL; Kirwan JP; Wolski K; Brethauer SA; Navaneethan SD; Aminian A; Pothier CE; Kim ES; Nissen SE; Kashyap SR;
N Engl J Med; 2014 May; 370(21):2002-13. PubMed ID: 24679060
[TBL] [Abstract][Full Text] [Related]
5. Bariatric surgery versus intensive medical therapy in obese patients with diabetes.
Schauer PR; Kashyap SR; Wolski K; Brethauer SA; Kirwan JP; Pothier CE; Thomas S; Abood B; Nissen SE; Bhatt DL
N Engl J Med; 2012 Apr; 366(17):1567-76. PubMed ID: 22449319
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of diabetes remission after bariatic surgery may be jeopardized by remission criteria and previous hypoglycemic treatment.
Ramos-Levi A; Sanchez-Pernaute A; Matia P; Cabrerizo L; Barabash A; Hernandez C; Calle-Pascual A; Torres A; Rubio M
Obes Surg; 2013 Oct; 23(10):1520-6. PubMed ID: 23702908
[TBL] [Abstract][Full Text] [Related]
7. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial.
Mingrone G; Panunzi S; De Gaetano A; Guidone C; Iaconelli A; Capristo E; Chamseddine G; Bornstein SR; Rubino F
Lancet; 2021 Jan; 397(10271):293-304. PubMed ID: 33485454
[TBL] [Abstract][Full Text] [Related]
8. Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis.
Panunzi S; De Gaetano A; Carnicelli A; Mingrone G
Ann Surg; 2015 Mar; 261(3):459-67. PubMed ID: 25361217
[TBL] [Abstract][Full Text] [Related]
9. Type 2 diabetes after gastric bypass: remission in five models using HbA1c, fasting blood glucose, and medication status.
Blackstone R; Bunt JC; Cortés MC; Sugerman HJ
Surg Obes Relat Dis; 2012; 8(5):548-55. PubMed ID: 22721581
[TBL] [Abstract][Full Text] [Related]
10. Remission of type 2 diabetes mellitus should not be the foremost goal after bariatric surgery.
Ramos-Levi AM; Sanchez-Pernaute A; Cabrerizo L; Matia P; Barabash A; Hernandez C; Calle-Pascual AL; Torres AJ; Rubio MA
Obes Surg; 2013 Dec; 23(12):2020-5. PubMed ID: 23893315
[TBL] [Abstract][Full Text] [Related]
11. Surgery for weight loss in adults.
Colquitt JL; Pickett K; Loveman E; Frampton GK
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD003641. PubMed ID: 25105982
[TBL] [Abstract][Full Text] [Related]
12. Predictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: A ten-year follow-up study.
Moriconi D; Manca ML; Anselmino M; Rebelos E; Bellini R; Taddei S; Ferrannini E; Nannipieri M
Diabetes Metab; 2022 Jan; 48(1):101282. PubMed ID: 34547450
[TBL] [Abstract][Full Text] [Related]
13. "Dual-remission" after Roux-en-Y gastric bypass surgery: Glycemic variability cannot always be improved in Chinese obese patients with type 2 diabetes.
Yu H; Zhou J; Bao Y; Pin Zhang ; Lu W; Jia W
Surg Obes Relat Dis; 2016 Aug; 12(7):1312-1319. PubMed ID: 26823091
[TBL] [Abstract][Full Text] [Related]
14. Metabolic intestinal bypass surgery for type 2 diabetes in patients with a BMI <35 kg/m2: comparative analysis of 16 patients undergoing either BPD, BPD-DS, or RYGB.
Frenken M; Cho EY
Obes Facts; 2011; 4 Suppl 1(Suppl 1):13-7. PubMed ID: 22027284
[TBL] [Abstract][Full Text] [Related]
15. Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial.
Hofsø D; Fatima F; Borgeraas H; Birkeland KI; Gulseth HL; Hertel JK; Johnson LK; Lindberg M; Nordstrand N; Cvancarova Småstuen M; Stefanovski D; Svanevik M; Gretland Valderhaug T; Sandbu R; Hjelmesæth J
Lancet Diabetes Endocrinol; 2019 Dec; 7(12):912-924. PubMed ID: 31678062
[TBL] [Abstract][Full Text] [Related]
16. Bariatric surgery or medicine for type 2 diabetes?
Doggrell SA; Chan V
Expert Opin Pharmacother; 2012 Oct; 13(15):2249-53. PubMed ID: 22957791
[TBL] [Abstract][Full Text] [Related]
17. What is the impact of sleeve gastrectomy and gastric bypass on metabolic control of diabetes? A clinic-based cohort of Mediterranean diabetic patients.
Bruno G; Gruden G; Barutta F; Cavallo Perin P; Morino M; Toppino M
Surg Obes Relat Dis; 2015; 11(5):1014-9. PubMed ID: 25979204
[TBL] [Abstract][Full Text] [Related]
18. Effect of Roux-en-Y gastric bypass with different pouch size in Chinese T2DM patients with BMI 30-35 kg/m2.
Ren Y; Yang W; Yang J; Wang C
Obes Surg; 2015 Mar; 25(3):457-63. PubMed ID: 25236397
[TBL] [Abstract][Full Text] [Related]
19. Potential of surgery for curing type 2 diabetes mellitus.
Rubino F; Gagner M
Ann Surg; 2002 Nov; 236(5):554-9. PubMed ID: 12409659
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Relapse of Hyperglycemia after Laparoscopic Roux-en-Y Gastric Bypass in T2DM Obese Patients: a 5-Year Follow-Up of 24 Cases.
Xiaosong W; Chongyu S; Xuqi S; Peiwu Y; Yongliang Z
Obes Surg; 2019 Apr; 29(4):1164-1168. PubMed ID: 30645722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
